Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (531-540 of 692) with videos related to

Pageof 70
Sort By:
Molecular Cancer Therapeutics|October 18, 2019
Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase InhibitionAgata Okonska, Saskja Bühler, Vasundhara Rao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2020
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy RegistryH J M Smit, J Aerts, M van den Heuvel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2013
High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasisRobert A A van Boerdonk, Johannes M A Daniels, Elisabeth Bloemena, et al.
Journal of Clinical Pathology|June 12, 2014
Combined sputum hypermethylation and eNose analysis for lung cancer diagnosisA Jasmijn Hubers, Paul Brinkman, Remco J Boksem, et al.
Cancer|October 31, 2023
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancerBianca A M H van Veggel, Anthonie J van der Wekken, Marthe S Paats, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2026
Erratum to 'Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis': [Annals of Oncology. Volume 36, Issue 11, November 2025, Pages 1389-1399]H S Rugo, E Tokunaga, H Iwata, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Lung Cancer in the NetherlandsLizza E L Hendriks, Anne-Marie C Dingemans, Dirk K M De Ruysscher, et al.
Lung Cancer (Amsterdam, Netherlands)|January 26, 2010
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studiesV Surmont, E F Smit, M de Jonge, et al.
European Journal of Cancer (Oxford, England : 1990)|January 5, 2010
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trialsMassimo Di Maio, Nicola Lama, Alessandro Morabito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancerPaul Roepman, Jacek Jassem, Egbert F Smit, et al.
Pageof 70

Showing results (531-540 of 692) with videos related to

Sort By:
Pageof 70
Molecular Cancer Therapeutics|October 18, 2019
Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase InhibitionAgata Okonska, Saskja Bühler, Vasundhara Rao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2020
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy RegistryH J M Smit, J Aerts, M van den Heuvel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2013
High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasisRobert A A van Boerdonk, Johannes M A Daniels, Elisabeth Bloemena, et al.
Journal of Clinical Pathology|June 12, 2014
Combined sputum hypermethylation and eNose analysis for lung cancer diagnosisA Jasmijn Hubers, Paul Brinkman, Remco J Boksem, et al.
Cancer|October 31, 2023
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancerBianca A M H van Veggel, Anthonie J van der Wekken, Marthe S Paats, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2026
Erratum to 'Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis': [Annals of Oncology. Volume 36, Issue 11, November 2025, Pages 1389-1399]H S Rugo, E Tokunaga, H Iwata, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Lung Cancer in the NetherlandsLizza E L Hendriks, Anne-Marie C Dingemans, Dirk K M De Ruysscher, et al.
Lung Cancer (Amsterdam, Netherlands)|January 26, 2010
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studiesV Surmont, E F Smit, M de Jonge, et al.
European Journal of Cancer (Oxford, England : 1990)|January 5, 2010
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trialsMassimo Di Maio, Nicola Lama, Alessandro Morabito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancerPaul Roepman, Jacek Jassem, Egbert F Smit, et al.
Pageof 70